Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

Sureka, Sanjoy Kumar; Misra, Ankit; Raj, Himanshu; Shukla, Anupam; Singh, Uday Pratap

Sureka, Sanjoy Kumar; Misra, Ankit; Raj, Himanshu; Shukla, Anupam; Singh, Uday Pratap.

Afiliação

Sureka SK; Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. drsksureka@gmail.com.
Misra A; Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Raj H; Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Shukla A; Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Singh UP; Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Int Urol Nephrol ; 55(5): 1133-1137, 2023 May.

Article em En | MEDLINE | ID: mdl-36917412

Assuntos

Próstata; Neoplasias da Próstata; Masculino; Humanos; Próstata/patologia; Antígeno Prostático Específico; Estudos Retrospectivos; Neoplasias da Próstata/patologia; Biópsia

Palavras-chave

Histopathology; Metastatic prostate cancer; Prostate specific antigen; Systematic core biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google